Agilent (A) Stock Forecast, Price Target & Predictions
A Stock Forecast
Agilent stock forecast is as follows: an average price target of $147.40 (represents a 9.58% upside from A’s last price of $134.51) and a rating consensus of 'Buy', based on 13 wall street analysts offering a 1-year stock forecast.
A Price Target
A Analyst Ratings
Buy
Agilent Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 15, 2024 | Luke Sergott | Barclays | $145.00 | $144.25 | 0.52% | 7.80% |
Oct 14, 2024 | Patrick Donnelly | Citigroup | $165.00 | $143.82 | 14.73% | 22.67% |
Oct 01, 2024 | Vijay Kumar | Evercore ISI | $145.00 | $148.48 | -2.34% | 7.80% |
Aug 22, 2024 | Michael Ryskin | Bank of America Securities | $147.00 | $139.99 | 5.01% | 9.29% |
Jul 22, 2024 | Brandon Couillard | Jefferies | $135.00 | $133.42 | 1.18% | 0.36% |
May 30, 2024 | Daniel Arias | Stifel Nicolaus | $151.00 | $133.57 | 13.05% | 12.26% |
May 30, 2024 | Catherine Schulte | Robert W. Baird | $136.00 | $145.48 | -6.52% | 1.11% |
May 30, 2024 | Matthew Sykes | Goldman Sachs | $145.00 | $145.48 | -0.33% | 7.80% |
Apr 04, 2024 | Daniel Arias | Stifel Nicolaus | $163.00 | $141.34 | 15.32% | 21.18% |
Nov 20, 2023 | Ross Muken | Evercore ISI | $120.00 | $113.15 | 6.05% | -10.79% |
Nov 20, 2023 | Jack Meehan | Barclays | $105.00 | $113.15 | -7.20% | -21.94% |
Jan 10, 2023 | Dan Leonard | Wells Fargo | $170.00 | $153.44 | 10.79% | 26.38% |
Jan 06, 2023 | Leerink Partners | $170.00 | $145.29 | 17.00% | 26.38% | |
Dec 20, 2022 | UBS | $170.00 | $147.67 | 15.12% | 26.38% | |
Nov 22, 2022 | Puneet Souda | Leerink Partners | $165.00 | $155.32 | 6.23% | 22.67% |
May 25, 2022 | Catherine Schulte | Robert W. Baird | $161.00 | $120.38 | 33.74% | 19.69% |
Apr 29, 2022 | Timothy Daley | Wells Fargo | $130.00 | $122.19 | 6.39% | -3.35% |
Agilent Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 3 | 9 |
Avg Price Target | - | $151.67 | $148.00 |
Last Closing Price | $134.51 | $134.51 | $134.51 |
Upside/Downside | -100.00% | 12.76% | 10.03% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Dec 17, 2024 | Goldman Sachs | Buy | Buy | Hold |
Oct 15, 2024 | Barclays | Underweight | Underweight | Hold |
Oct 14, 2024 | Citigroup | Buy | Buy | Hold |
Oct 01, 2024 | Evercore ISI | Positive | Positive | Hold |
Aug 27, 2024 | Wells Fargo | Equal-Weight | Overweight | Initialise |
Aug 23, 2024 | Barclays | Underweight | Underweight | Hold |
Aug 22, 2024 | Cowen & Co. | Buy | Buy | Hold |
Aug 22, 2024 | Citigroup | Buy | Buy | Hold |
Aug 01, 2024 | William Blair | Outperform | Outperform | Hold |
Jul 22, 2024 | Jefferies | Hold | Hold | Hold |
Jul 10, 2024 | Citigroup | Neutral | Buy | Upgrade |
Jun 27, 2024 | Wolfe Research | Peer Perform | Downgrade | |
Jun 24, 2024 | Citigroup | Neutral | Neutral | Hold |
Jun 03, 2024 | Jefferies | Buy | Hold | Downgrade |
May 30, 2024 | Cowen & Co. | Buy | Buy | Hold |
May 30, 2024 | Citigroup | Neutral | Neutral | Hold |
May 30, 2024 | Bank of America Securities | Neutral | Neutral | Hold |
May 30, 2024 | Goldman Sachs | Buy | Buy | Hold |
Dec 07, 2023 | Goldman Sachs | Buy | Buy | Hold |
Nov 21, 2023 | RBC Capital | Outperform | Outperform | Hold |
Nov 20, 2023 | Barclays | Underweight | Underweight | Hold |
Nov 20, 2023 | Jefferies | Buy | Buy | Hold |
Aug 16, 2023 | Barclays | Underweight | Underweight | Hold |
Aug 16, 2023 | Credit Suisse | Outperform | Outperform | Hold |
May 24, 2023 | Goldman Sachs | Buy | Buy | Hold |
May 24, 2023 | Wells Fargo | Overweight | Equal-Weight | Initialise |
May 24, 2023 | Barclays | Overweight | Initialise | |
Jan 06, 2023 | SVB Leerink | Outperform | Outperform | Hold |
Dec 20, 2022 | UBS | Buy | Buy | Hold |
Nov 22, 2022 | Citigroup | Neutral | Neutral | Hold |
Nov 22, 2022 | SVB Leerink | Overweight | Overweight | Hold |
May 31, 2022 | Bank of America Securities | Buy | Buy | Hold |
Feb 23, 2022 | Wells Fargo | Overweight | Overweight | Hold |
Feb 23, 2022 | Citigroup | Buy | Buy | Hold |
Feb 23, 2022 | SVB Leerink | Outperform | Outperform | Hold |
Agilent Financial Forecast
Agilent Revenue Forecast
Quarter
Oct 27 | Jul 27 | Apr 27 | Jan 27 | Oct 26 | Jul 26 | Apr 26 | Jan 26 | Oct 25 | Jul 25 | Apr 25 | Jan 25 | Oct 24 | Jul 24 | Apr 24 | Jan 24 | Oct 23 | Jul 23 | Apr 23 | Jan 23 | Oct 22 | Jul 22 | May 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.66B | $1.69B | $1.67B | $1.72B | $1.76B | $1.85B | $1.72B | - | $1.67B | $1.66B | $1.59B | - | $1.55B | $1.48B | $1.26B |
Avg Forecast | $2.03B | $1.92B | $1.87B | $1.90B | $1.92B | $1.79B | $1.76B | $1.77B | $1.82B | $1.69B | $1.65B | $1.67B | $1.67B | $1.56B | $1.58B | $1.59B | $1.67B | $1.66B | $1.68B | $1.70B | $1.76B | $1.64B | $1.62B | $1.65B | $1.66B | $1.54B | $1.39B | $1.44B | $1.40B | $1.21B |
High Forecast | $2.04B | $1.92B | $1.88B | $1.90B | $1.93B | $1.80B | $1.77B | $1.78B | $1.82B | $1.69B | $1.66B | $1.67B | $1.68B | $1.56B | $1.58B | $1.59B | $1.69B | $1.67B | $1.69B | $1.71B | $1.78B | $1.66B | $1.64B | $1.67B | $1.68B | $1.56B | $1.41B | $1.46B | $1.42B | $1.23B |
Low Forecast | $2.03B | $1.91B | $1.87B | $1.89B | $1.92B | $1.79B | $1.75B | $1.77B | $1.81B | $1.68B | $1.65B | $1.66B | $1.67B | $1.56B | $1.58B | $1.59B | $1.66B | $1.66B | $1.68B | $1.70B | $1.73B | $1.61B | $1.59B | $1.63B | $1.63B | $1.52B | $1.37B | $1.42B | $1.38B | $1.19B |
# Analysts | 7 | 4 | 6 | 4 | 7 | 4 | 6 | 4 | 6 | 3 | 5 | 8 | 10 | 5 | 6 | 4 | 9 | 4 | 5 | 4 | 3 | 6 | 3 | 3 | 4 | 6 | 4 | 4 | 9 | 9 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 1.01% | 1.01% | 1.02% | 1.03% | 1.05% | 1.05% | - | 1.01% | 1.00% | 1.03% | - | 1.07% | 1.06% | 1.04% |
Forecast
Agilent EBITDA Forecast
Quarter
Oct 27 | Jul 27 | Apr 27 | Jan 27 | Oct 26 | Jul 26 | Apr 26 | Jan 26 | Oct 25 | Jul 25 | Apr 25 | Jan 25 | Oct 24 | Jul 24 | Apr 24 | Jan 24 | Oct 23 | Jul 23 | Apr 23 | Jan 23 | Oct 22 | Jul 22 | May 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 7 | 4 | 6 | 4 | 7 | 4 | 6 | 4 | 6 | 3 | 5 | 8 | 10 | 5 | 6 | 4 | 9 | 4 | 5 | 4 | 3 | 6 | 3 | 3 | 4 | 6 | 4 | 4 | 9 | 9 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $384.00M | $504.00M | $227.00M | $472.00M | $502.00M | $551.00M | $496.00M | - | $422.00M | $553.00M | $432.00M | - | $407.00M | $378.00M | $315.00M |
Avg Forecast | $527.12M | $496.84M | $485.63M | $491.68M | $498.59M | $463.83M | $455.96M | $459.06M | $470.91M | $436.79M | $428.19M | $432.40M | $433.32M | $403.49M | $497.64M | $411.26M | $432.25M | $430.07M | $452.40M | $587.50M | $448.77M | $417.55M | $411.27M | $421.69M | $423.01M | $392.86M | $384.13M | $367.32M | $356.99M | $308.95M |
High Forecast | $528.83M | $498.45M | $487.20M | $493.27M | $500.20M | $465.33M | $457.43M | $460.55M | $472.44M | $438.21M | $429.58M | $433.80M | $435.91M | $403.49M | $597.17M | $411.26M | $437.43M | $431.46M | $542.88M | $705.00M | $454.52M | $422.89M | $493.53M | $427.09M | $428.42M | $397.89M | $460.96M | $372.02M | $361.56M | $312.91M |
Low Forecast | $525.64M | $495.44M | $484.26M | $490.29M | $497.18M | $462.52M | $454.67M | $457.77M | $469.58M | $435.56M | $426.98M | $431.18M | $432.10M | $403.49M | $398.11M | $411.26M | $429.66M | $428.85M | $361.92M | $470.00M | $441.91M | $411.16M | $329.02M | $415.24M | $416.54M | $386.85M | $307.31M | $361.70M | $351.54M | $304.23M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.93% | 1.17% | 0.53% | 1.04% | 0.85% | 1.23% | 1.19% | - | 1.00% | 1.31% | 1.10% | - | 1.11% | 1.06% | 1.02% |
Forecast
Agilent Net Income Forecast
Quarter
Oct 27 | Jul 27 | Apr 27 | Jan 27 | Oct 26 | Jul 26 | Apr 26 | Jan 26 | Oct 25 | Jul 25 | Apr 25 | Jan 25 | Oct 24 | Jul 24 | Apr 24 | Jan 24 | Oct 23 | Jul 23 | Apr 23 | Jan 23 | Oct 22 | Jul 22 | May 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 7 | 4 | 6 | 4 | 7 | 4 | 6 | 4 | 6 | 3 | 5 | 8 | 10 | 5 | 6 | 4 | 9 | 4 | 5 | 4 | 3 | 6 | 3 | 3 | 4 | 6 | 4 | 4 | 9 | 9 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $348.00M | $475.00M | $111.00M | $302.00M | $352.00M | $368.00M | $329.00M | - | $283.00M | $442.00M | $264.00M | - | $288.00M | $222.00M | $199.00M |
Avg Forecast | $542.80M | $489.58M | $454.59M | $447.48M | $477.58M | $437.66M | $408.60M | $405.50M | $453.37M | $402.92M | $375.15M | $364.86M | $404.71M | $361.32M | $333.72M | $351.55M | $385.29M | $391.63M | $303.39M | $469.58M | $402.95M | $349.51M | $275.81M | $342.47M | $342.22M | $289.18M | $271.82M | $262.58M | $270.15M | $192.86M |
High Forecast | $545.08M | $491.64M | $456.51M | $449.37M | $479.59M | $439.51M | $410.32M | $407.21M | $455.28M | $404.62M | $376.73M | $367.74M | $407.58M | $361.33M | $400.47M | $351.56M | $391.04M | $393.28M | $364.06M | $563.49M | $409.65M | $355.32M | $330.97M | $348.17M | $347.92M | $293.99M | $326.18M | $266.94M | $274.65M | $196.07M |
Low Forecast | $540.81M | $487.78M | $452.92M | $445.84M | $475.83M | $436.06M | $407.10M | $404.02M | $451.71M | $401.44M | $373.77M | $361.99M | $401.84M | $361.32M | $266.98M | $351.53M | $382.41M | $390.19M | $242.71M | $375.66M | $394.94M | $342.56M | $220.64M | $335.67M | $335.42M | $283.43M | $217.46M | $257.36M | $264.78M | $189.03M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 1.23% | 0.28% | 1.00% | 0.75% | 0.91% | 0.94% | - | 0.83% | 1.29% | 0.91% | - | 1.10% | 0.82% | 1.03% |
Forecast
Agilent SG&A Forecast
Quarter
Oct 27 | Jul 27 | Apr 27 | Jan 27 | Oct 26 | Jul 26 | Apr 26 | Jan 26 | Oct 25 | Jul 25 | Apr 25 | Jan 25 | Oct 24 | Jul 24 | Apr 24 | Jan 24 | Oct 23 | Jul 23 | Apr 23 | Jan 23 | Oct 22 | Jul 22 | May 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 7 | 4 | 6 | 4 | 7 | 4 | 6 | 4 | 6 | 3 | 5 | 8 | 10 | 5 | 6 | 4 | 9 | 4 | 5 | 4 | 3 | 6 | 3 | 3 | 4 | 6 | 4 | 4 | 9 | 9 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $396.00M | $393.00M | $407.00M | $415.00M | $419.00M | $422.00M | $412.00M | - | $417.00M | $389.00M | $403.00M | - | $407.00M | $387.00M | $347.00M |
Avg Forecast | $510.87M | $481.52M | $470.66M | $476.52M | $483.22M | $449.53M | $441.90M | $444.91M | $456.40M | $423.33M | $414.99M | $419.07M | $419.96M | $391.05M | $491.74M | $398.58M | $418.93M | $416.81M | $447.04M | $413.27M | $456.65M | $424.88M | $406.40M | $429.10M | $430.44M | $399.76M | $384.13M | $373.77M | $363.26M | $314.38M |
High Forecast | $512.53M | $483.08M | $472.18M | $478.07M | $484.78M | $450.99M | $443.33M | $446.35M | $457.87M | $424.70M | $416.34M | $420.43M | $422.48M | $391.05M | $590.09M | $398.58M | $423.94M | $418.16M | $536.45M | $495.93M | $462.50M | $430.32M | $487.68M | $434.59M | $435.95M | $404.87M | $460.96M | $378.55M | $367.91M | $318.40M |
Low Forecast | $509.43M | $480.17M | $469.33M | $475.18M | $481.85M | $448.26M | $440.65M | $443.66M | $455.11M | $422.13M | $413.82M | $417.89M | $418.78M | $391.05M | $393.39M | $398.58M | $416.42M | $415.63M | $357.63M | $330.62M | $449.67M | $418.38M | $325.12M | $422.54M | $423.86M | $393.65M | $307.31M | $368.05M | $357.71M | $309.57M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 0.94% | 0.98% | 0.93% | 1.01% | 0.92% | 0.97% | - | 0.97% | 0.90% | 1.01% | - | 1.09% | 1.07% | 1.10% |
Forecast
Agilent EPS Forecast
Quarter
Oct 27 | Jul 27 | Apr 27 | Jan 27 | Oct 26 | Jul 26 | Apr 26 | Jan 26 | Oct 25 | Jul 25 | Apr 25 | Jan 25 | Oct 24 | Jul 24 | Apr 24 | Jan 24 | Oct 23 | Jul 23 | Apr 23 | Jan 23 | Oct 22 | Jul 22 | May 22 | Jan 22 | Oct 21 | Jul 21 | May 21 | Jan 21 | Oct 20 | Jul 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 7 | 4 | 6 | 4 | 7 | 4 | 6 | 4 | 6 | 3 | 5 | 8 | 10 | 5 | 6 | 4 | 9 | 4 | 5 | 4 | 3 | 6 | 3 | 3 | 4 | 6 | 4 | 4 | 9 | 9 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.18 | $1.63 | $0.38 | $1.02 | $1.19 | $1.24 | $1.10 | - | $0.94 | $1.46 | $0.87 | - | $0.94 | $0.72 | $0.64 |
Avg Forecast | $1.89 | $1.71 | $1.58 | $1.56 | $1.66 | $1.52 | $1.42 | $1.41 | $1.58 | $1.40 | $1.31 | $1.27 | $1.41 | $1.26 | $1.19 | $1.22 | $1.34 | $1.36 | $1.26 | $1.31 | $1.38 | $1.20 | $1.12 | $1.18 | $1.18 | $0.99 | $0.83 | $0.90 | $0.93 | $0.66 |
High Forecast | $1.90 | $1.71 | $1.59 | $1.57 | $1.67 | $1.53 | $1.43 | $1.42 | $1.59 | $1.41 | $1.31 | $1.28 | $1.42 | $1.26 | $1.19 | $1.22 | $1.36 | $1.37 | $1.27 | $1.32 | $1.41 | $1.22 | $1.14 | $1.20 | $1.20 | $1.01 | $0.85 | $0.92 | $0.94 | $0.67 |
Low Forecast | $1.88 | $1.70 | $1.58 | $1.55 | $1.66 | $1.52 | $1.42 | $1.41 | $1.57 | $1.40 | $1.30 | $1.26 | $1.40 | $1.26 | $1.19 | $1.22 | $1.33 | $1.36 | $1.26 | $1.31 | $1.36 | $1.18 | $1.10 | $1.15 | $1.15 | $0.97 | $0.82 | $0.88 | $0.91 | $0.65 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.96% | 1.21% | 0.28% | 0.81% | 0.91% | 0.90% | 0.92% | - | 0.80% | 1.24% | 0.88% | - | 1.04% | 0.78% | 0.97% |
Forecast
Agilent Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
DHR | Danaher | $233.53 | $292.40 | 25.21% | Buy |
TMO | Thermo Fisher Scientific | $528.84 | $640.88 | 21.19% | Buy |
IDXX | IDEXX Laboratories | $427.09 | $510.00 | 19.41% | Buy |
GH | Guardant Health | $34.84 | $40.60 | 16.53% | Buy |
MTD | Mettler-Toledo | $1.25K | $1.41K | 13.28% | Hold |
RVTY | Revvity | $114.75 | $127.86 | 11.42% | Buy |
CRL | Charles River Laboratories | $189.33 | $209.00 | 10.39% | Buy |
A | Agilent | $136.46 | $147.40 | 8.02% | Buy |
ILMN | Illumina | $143.12 | $147.78 | 3.26% | Buy |
WAT | Waters | $373.72 | $356.80 | -4.53% | Buy |